AAAAAA

   
Results: 1-13 |
Results: 13
p53 as a drug target in cancer therapy
Authors: Chene, P
Citation: P. Chene, p53 as a drug target in cancer therapy, EXPERT OP T, 11(6), 2001, pp. 923-935
Coupling of the antennapedia third helix to a potent antagonist of the p53/hdm2 protein-protein interaction
Authors: Garcia-Echeverria, C Furet, P Chene, P
Citation: C. Garcia-echeverria et al., Coupling of the antennapedia third helix to a potent antagonist of the p53/hdm2 protein-protein interaction, BIOORG MED, 11(16), 2001, pp. 2161-2164
The role of tetramerization in p53 function
Authors: Chene, P
Citation: P. Chene, The role of tetramerization in p53 function, ONCOGENE, 20(21), 2001, pp. 2611-2617
Fast, qualitative analysis of p53 phosphorylation by protein kinases
Authors: Chene, P
Citation: P. Chene, Fast, qualitative analysis of p53 phosphorylation by protein kinases, BIOTECHNIQU, 28(2), 2000, pp. 240-242
A small synthetic peptide, which inhibits the p53-hmd2 interaction, stimulates the p53 pathway in tumour cell (vol 299, pg 245, 2000)
Authors: Chene, P
Citation: P. Chene, A small synthetic peptide, which inhibits the p53-hmd2 interaction, stimulates the p53 pathway in tumour cell (vol 299, pg 245, 2000), J MOL BIOL, 302(3), 2000, pp. 747-747
A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines
Authors: Chene, P Fuchs, J Bohn, J Garcia-Echeverria, C Furet, P Fabbro, D
Citation: P. Chene et al., A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines, J MOL BIOL, 299(1), 2000, pp. 245-253
Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53
Authors: Garcia-Echeverria, C Chene, P Blommers, MJJ Furet, P
Citation: C. Garcia-echeverria et al., Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53, J MED CHEM, 43(17), 2000, pp. 3205-3208
p53 transdominance but no gain of function in mouse brain tumor model
Authors: Hegi, ME Klein, MA Ruedi, D Chene, P Hamon, MF Aguzzi, A
Citation: Me. Hegi et al., p53 transdominance but no gain of function in mouse brain tumor model, CANCER RES, 60(11), 2000, pp. 3019-3024
Influence of the N-terminal region on the oligomerisation between human and Xenopus laevis p53
Authors: Chene, P
Citation: P. Chene, Influence of the N-terminal region on the oligomerisation between human and Xenopus laevis p53, J MOL BIOL, 288(5), 1999, pp. 883-890
Cellular characterisation of p53 mutants with a single missense mutation in the beta-strand 326-333 and correlation of their cellular activities within vitro properties
Authors: Chene, P Bechter, E
Citation: P. Chene et E. Bechter, Cellular characterisation of p53 mutants with a single missense mutation in the beta-strand 326-333 and correlation of their cellular activities within vitro properties, J MOL BIOL, 288(5), 1999, pp. 891-897
p53 mutants without a functional tetramerisation domain are not oncogenic
Authors: Chene, P Bechter, E
Citation: P. Chene et E. Bechter, p53 mutants without a functional tetramerisation domain are not oncogenic, J MOL BIOL, 286(5), 1999, pp. 1269-1274
Functional analyses of a unique p53 germline mutant (Y236 Delta) associated with a familial brain tumor syndrome
Authors: Chene, P Ory, K Ruedi, D Soussi, T Hegi, ME
Citation: P. Chene et al., Functional analyses of a unique p53 germline mutant (Y236 Delta) associated with a familial brain tumor syndrome, INT J CANC, 82(1), 1999, pp. 17-22
Mutations at position 277 modify the DNA-binding specificity of human p53 in vitro
Authors: Chene, P
Citation: P. Chene, Mutations at position 277 modify the DNA-binding specificity of human p53 in vitro, BIOC BIOP R, 263(1), 1999, pp. 1-5
Risultati: 1-13 |